Animal Blood Bank Market Size, Share and Growth Outlook, 2026

Animal Blood Bank Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Animal Blood Bank Market size is forecast to increase from $4.6 Billion in 2026 to $8.02 Billion in 2034 at a CAGR of 7.2% between 2026 and 2034.

The Animal Blood Bank market report provides detailed analysis and outlook of Animal Blood Bank segments including By Product (Whole Blood, Packed Red Blood Cells (PRBCs), Plasma Products, Platelet Concentrates, Serum and Immunoglobulins), By Species (Canine, Feline, Equine, Livestock ), By Operational Structure (Standalone Blood Banks, Institution-Attached ), By Application (Emergency and Trauma Care, Surgical Procedures, Chronic Disease Management, Infectious Disease Treatment), By End-User (Veterinary Hospitals and Clinics, Academic and Veterinary Research Institutes, Commercial Veterinary Laboratories) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Animal Blood Bank Industry Overview

Expanding Veterinary Transfusion Services Supporting Clinical Care

The animal blood bank industry is becoming an increasingly important component of veterinary healthcare as demand grows for specialized transfusion medicine services across companion animal and livestock care settings. Veterinary professionals are seeking greater access to high-quality blood products, standardized transfusion protocols, and expert clinical support to improve outcomes in critical care, emergency medicine, surgery, and trauma management. Industry participants are expanding services beyond blood collection and distribution to include clinical consultation, education, and transfusion management support. These developments are helping strengthen veterinary transfusion infrastructure while improving access to lifesaving blood products for animal patients.

Specialist Consultation Services Enhancing Transfusion Outcomes

The industry is witnessing increased investment in clinical support programs designed to improve transfusion practices and patient outcomes. A notable development is the collaboration between Pet Blood Bank UK and the Royal Veterinary College to establish a free transfusion advice service for veterinarians. The initiative provides direct access to specialist expertise for managing complex transfusion cases and supports the standardization of treatment approaches across veterinary practices. By improving access to professional guidance and evidence-based transfusion management, such programs help veterinary clinics deliver more consistent and effective care for animals requiring blood products during emergency and critical care situations.

Funding Initiatives Expanding Access to Lifesaving Blood Products

Charitable support continues to play a significant role in improving access to veterinary transfusion services. Pet Blood Bank UK received a grant of £5,000 to provide lifesaving blood products free of charge for veterinary charity patients. Funding initiatives of this nature help address financial barriers to treatment and ensure that animals requiring urgent transfusions can receive appropriate care regardless of economic constraints. Increased collaboration between blood banks, veterinary institutions, and charitable organizations is supporting broader accessibility to transfusion medicine services while strengthening the overall veterinary healthcare ecosystem.

Regulatory Standardization Strengthening Industry Development

Regulatory oversight and biosafety standards are becoming increasingly important within the animal blood bank industry. Government agencies are implementing frameworks to improve donor screening, blood collection practices, biosafety requirements, and cross-matching procedures. A significant milestone was the establishment of the National Veterinary Blood Bank Network by the Indian Ministry of Fisheries, Animal Husbandry and Dairying. The framework introduced standardized requirements for donor eligibility, biosafety protocols, and transfusion safety practices, helping address previously fragmented regulatory conditions. Regulatory enforcement efforts have also intensified, as demonstrated by investigations into unauthorized blood collection activities involving sheep and goat blood at a facility in Hyderabad. These actions reflect growing commitment to ethical collection practices, clinical safety, and regulatory compliance across the veterinary transfusion medicine sector.

Animal Blood Bank Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Animal Blood Bank market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Hemopet (Hemolife), Blue Ridge Veterinary Blood Bank, Animal Blood Resources International (ABRI), Eastern Veterinary Blood Bank, HemoSA (Pty) Ltd, Pet Blood Bank UK, Canine Blood Bank, North Carolina State Veterinary Blood Bank, California Veterinary Blood Bank, Penn Vet Blood Bank. The Animal Blood Bank market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Animal Blood Bank industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Animal Blood Bank Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Animal Blood Bank companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Animal Blood Bank markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Animal Blood Bank Market Competitive Benchmarking and Company Analysis

Leading companies in Animal Blood Bank industry include- Hemopet (Hemolife), Blue Ridge Veterinary Blood Bank, Animal Blood Resources International (ABRI), Eastern Veterinary Blood Bank, HemoSA (Pty) Ltd, Pet Blood Bank UK, Canine Blood Bank, North Carolina State Veterinary Blood Bank, California Veterinary Blood Bank, Penn Vet Blood Bank. The Animal Blood Bank market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Animal Blood Bank Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Animal Blood Bank market remains one of the strongest-performing segments in the country.
The US Animal Blood Bank Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Animal Blood Bank market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Animal Blood Bank industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Animal Blood Bank markets

Canada's strong Animal Blood Bank sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Animal Blood Bank market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Animal Blood Bank Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Animal Blood Bank market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Animal Blood Bank population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Animal Blood Bank industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Animal Blood Bank market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Animal Blood Bank sales through 2034

France Animal Blood Bank companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Animal Blood Bank Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Animal Blood Bank distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Animal Blood Bank Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Animal Blood Bank market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Animal Blood Bank industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Animal Blood Bank industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Animal Blood Bank Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Animal Blood Bank market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Animal Blood Bank market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Animal Blood Bank Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Animal Blood Bank Market Segmentation

By Product
Whole Blood
Packed Red Blood Cells (PRBCs)
Plasma Products
Platelet Concentrates
Serum and Immunoglobulins
By Species
Canine
Feline
Equine
Livestock
By Operational Structure
Standalone Blood Banks
Institution-Attached
By Application
Emergency and Trauma Care
Surgical Procedures
Chronic Disease Management
Infectious Disease Treatment
By End-User
Veterinary Hospitals and Clinics
Academic and Veterinary Research Institutes
Commercial Veterinary Laboratories

Top Companies in Animal Blood Bank Industry

Hemopet (Hemolife)
Blue Ridge Veterinary Blood Bank
Animal Blood Resources International (ABRI)
Eastern Veterinary Blood Bank
HemoSA (Pty) Ltd
Pet Blood Bank UK
Canine Blood Bank
North Carolina State Veterinary Blood Bank
California Veterinary Blood Bank
Penn Vet Blood Bank

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025